gptkbp:instance_of
|
gptkb:Planned_Parenthood
|
gptkbp:approves
|
gptkb:1993
|
gptkbp:available_in
|
gptkb:various_countries
|
gptkbp:brand
|
gptkb:Loestrin
|
gptkbp:clinical_trial
|
studies on efficacy
studies on safety
studies on side effects
|
gptkbp:contains
|
gptkb:norethindrone_acetate
gptkb:ethinyl_estradiol
|
gptkbp:contraindication
|
liver disease
certain cancers
history of blood clots
smoking over age 35
|
gptkbp:discontinued
|
no
|
gptkbp:dosage_form
|
21-day regimen
28-day regimen
21 tablets per cycle
|
gptkbp:duration
|
monthly
|
gptkbp:formulation
|
gptkb:tablet
|
https://www.w3.org/2000/01/rdf-schema#label
|
Loestrin 21
|
gptkbp:ingredients
|
gptkb:norethindrone
gptkb:ethinyl_estradiol
|
gptkbp:interacts_with
|
antibiotics
anticonvulsants
HIV medications
|
gptkbp:is_effective_against
|
over 99% with perfect use
91% with typical use
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
gptkbp:marketed_as
|
gptkb:Loestrin_24_Fe
Loestrin 21 Fe
|
gptkbp:packaging
|
blister pack
|
gptkbp:patient_population
|
available online
provided by pharmacists
|
gptkbp:previous_name
|
gptkb:norethindrone/ethinyl_estradiol
|
gptkbp:regulatory_compliance
|
gptkb:FDA
gptkb:EMA
|
gptkbp:requires
|
gptkb:true
|
gptkbp:side_effect
|
gptkb:depression
headache
nausea
hypertension
migraines
weight gain
breast tenderness
thromboembolism
consult healthcare provider
gallbladder disease
monitor for severe reactions
|
gptkbp:storage
|
room temperature
away from moisture
away from light
|
gptkbp:symptoms
|
headaches
acne
mood changes
irregular periods
|
gptkbp:type_of_care
|
important for effectiveness
|
gptkbp:used_for
|
birth control
|
gptkbp:bfsParent
|
gptkb:Loestrin
|
gptkbp:bfsLayer
|
7
|